Your browser doesn't support javascript.
loading
Physiology-guided PCI versus CABG for left main coronary artery disease: insights from the DEFINE-LM registry.
Warisawa, Takayuki; Cook, Christopher M; Kawase, Yoshiaki; Howard, James P; Ahmad, Yousif; Seligman, Henry; Rajkumar, Christopher; Toya, Takumi; Doi, Shunichi; Nakajima, Akihiro; Tanigaki, Toru; Omori, Hiroyuki; Nakayama, Masafumi; Vera-Urquiza, Rafael; Yuasa, Sonoka; Sato, Takao; Kikuta, Yuetsu; Nishina, Hidetaka; Al-Lamee, Rasha; Sen, Sayan; Lerman, Amir; Akashi, Yoshihiro J; Escaned, Javier; Matsuo, Hitoshi; Davies, Justin E.
Afiliação
  • Warisawa T; Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Kawasaki City, Kanagawa Prefecture, 216-8511, Japan. warisawa-tky@umin.ac.jp.
  • Cook CM; Department of Cardiovascular Medicine, NTT Medical Center Tokyo, Tokyo, Japan. warisawa-tky@umin.ac.jp.
  • Kawase Y; National Heart and Lung Institute, Imperial College London, London, UK. warisawa-tky@umin.ac.jp.
  • Howard JP; The Essex Cardiothoracic Centre, Basildon, UK.
  • Ahmad Y; Anglia Ruskin University, Chelmsford, UK.
  • Seligman H; Department of Cardiovascular Medicine, Gifu Heart Center, Gifu, Japan.
  • Rajkumar C; National Heart and Lung Institute, Imperial College London, London, UK.
  • Toya T; Cardiovascular Science, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Doi S; Cardiovascular Medicine, Yale School of Medicine, New Haven, USA.
  • Nakajima A; National Heart and Lung Institute, Imperial College London, London, UK.
  • Tanigaki T; Cardiovascular Science, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Omori H; National Heart and Lung Institute, Imperial College London, London, UK.
  • Nakayama M; Cardiovascular Science, Hammersmith Hospital, Imperial College Healthcare NHS Trust, London, UK.
  • Vera-Urquiza R; Department of Cardiology, National Defense Medical College, Tokorozawa, Japan.
  • Yuasa S; Department of Cardiovascular Medicine, Mayo Clinic, Rochester, USA.
  • Sato T; Division of Cardiology, Department of Internal Medicine, St. Marianna University School of Medicine, 2-16-1 Sugao, Kawasaki City, Kanagawa Prefecture, 216-8511, Japan.
  • Kikuta Y; Department of Cardiovascular Medicine, New Tokyo Hospital, Matsudo, Japan.
  • Nishina H; Department of Cardiovascular Medicine, Gifu Heart Center, Gifu, Japan.
  • Al-Lamee R; Department of Cardiovascular Medicine, Gifu Heart Center, Gifu, Japan.
  • Sen S; Department of Cardiovascular Medicine, Gifu Heart Center, Gifu, Japan.
  • Lerman A; Cardiovascular Center, Toda Central General Hospital, Toda, Japan.
  • Akashi YJ; Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain.
  • Escaned J; Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain.
  • Matsuo H; Department of Cardiology, Tachikawa General Hospital, Nagaoka, Japan.
  • Davies JE; National Heart and Lung Institute, Imperial College London, London, UK.
Cardiovasc Interv Ther ; 38(3): 287-298, 2023 Jul.
Article em En | MEDLINE | ID: mdl-37017899
There have been no studies comparing clinical outcomes of physiology-guided revascularization in patients with unprotected left main coronary disease (ULMD) between percutaneous coronary intervention (PCI) vs. coronary artery bypass grafting (CABG). The aim of this study was to assess the long-term clinical outcomes between PCI and CABG of patients with physiologically significant ULMD. From an international multicenter registry of ULMD patients interrogated with instantaneous wave-free ratio (iFR), we analyzed data from 151 patients (85 PCI vs. 66 CABG) who underwent revascularization according to the cutoff value of iFR ≤ 0.89. Propensity score matching was employed to adjust for baseline clinical characteristics. The primary endpoint was a composite of all-cause death, non-fatal myocardial infarction, and ischemia-driven target lesion revascularization. The secondary endpoints were the individual components of the primary endpoint. Mean age was 66.6 (± 9.2) years, 79.2% male. Mean SYNTAX score was 22.6 (± 8.4) and median iFR was 0.83 (IQR 0.74-0.87). After performing propensity score matching analysis, 48 patients treated with CABG were matched to those who underwent PCI. At a median follow-up period of 2.8 years, the primary endpoint occurred in 8.3% in PCI group and 20.8% in CABG group, respectively (HR 3.80; 95% CI 1.04-13.9; p = 0.043). There was no difference in each component of the primary event (p > 0.05 for all). Within the present study, iFR-guided PCI was associated with lower cardiovascular events rate in patients with ULMD and intermediate SYNTAX score, as compared to CABG. State-of-the-art PCI vs. CABG for ULMD. Study design and primary endpoint in patients with physiologically significant ULMD. MACE was defined as the composite of all-cause death, non-fatal myocardial infarction, and target lesion revascularization. The blue line denotes the PCI arm, and the red line denotes the CABG arm. PCI was associated with significantly lower risk of MACE than CABG. CABG: coronary artery bypass grafting; iFR: instantaneous wave-free ratio; MACE: major adverse cardiovascular events; PCI: percutaneous coronary intervention; ULMD: unprotected left main coronary artery disease.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Intervenção Coronária Percutânea / Infarto do Miocárdio Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Cardiovasc Interv Ther Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença da Artéria Coronariana / Intervenção Coronária Percutânea / Infarto do Miocárdio Tipo de estudo: Clinical_trials / Diagnostic_studies / Etiology_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male Idioma: En Revista: Cardiovasc Interv Ther Ano de publicação: 2023 Tipo de documento: Article